(Q38054989)

27 August 2017

title

Tafluprost: the first preservative-free prostaglandin to treat open-angle glaucoma and ocular hypertension (English)

1 reference

27 August 2017

1 reference

Cory Swymer

1

1 reference

27 August 2017

Michael W Neville

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

23 October 2012

1 reference

Annals of Pharmacotherapy

27 August 2017

published in

1 reference

27 August 2017

volume

46

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

1506-1510

1 reference

Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma.

27 August 2017

cites work

1 reference

Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma

21 January 2018

1 reference

The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo

21 January 2018

1 reference

A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension

21 January 2018

1 reference

IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma

21 January 2018

1 reference

Randomized Clinical Trial of the Efficacy and Safety of Preservative-free Tafluprost and Timolol in Patients With Open-Angle Glaucoma or Ocular Hypertension

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1R229

1 reference

27 August 2017

1 reference